Autonomix Medical (AMIX) Competitors $1.11 -0.05 (-4.31%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.12 +0.01 (+0.90%) As of 09/12/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMIX vs. COCH, ICU, RVP, NRXS, PETV, IRIX, DRIO, NXGL, ALUR, and INBSShould you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Envoy Medical (COCH), SeaStar Medical (ICU), Retractable Technologies (RVP), NeurAxis (NRXS), PetVivo (PETV), IRIDEX (IRIX), DarioHealth (DRIO), NexGel (NXGL), Allurion Technologies (ALUR), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical equipment" industry. Autonomix Medical vs. Its Competitors Envoy Medical SeaStar Medical Retractable Technologies NeurAxis PetVivo IRIDEX DarioHealth NexGel Allurion Technologies Intelligent Bio Solutions Autonomix Medical (NASDAQ:AMIX) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Does the media prefer AMIX or COCH? In the previous week, Autonomix Medical had 1 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for Autonomix Medical and 3 mentions for Envoy Medical. Autonomix Medical's average media sentiment score of 0.86 beat Envoy Medical's score of 0.15 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer AMIX or COCH? Autonomix Medical presently has a consensus target price of $5.00, indicating a potential upside of 350.45%. Envoy Medical has a consensus target price of $9.25, indicating a potential upside of 617.05%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Autonomix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is AMIX or COCH more profitable? Autonomix Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -172.93% -133.39% Envoy Medical -10,961.26%N/A -236.14% Which has more risk and volatility, AMIX or COCH? Autonomix Medical has a beta of -2.97, suggesting that its share price is 397% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.2, suggesting that its share price is 120% more volatile than the S&P 500. Which has stronger valuation and earnings, AMIX or COCH? Autonomix Medical has higher earnings, but lower revenue than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$11.41M-$5.74-0.19Envoy Medical$220K126.19-$20.80M-$1.43-0.90 Do institutionals & insiders believe in AMIX or COCH? 10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 58.9% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryEnvoy Medical beats Autonomix Medical on 8 of the 15 factors compared between the two stocks. Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMIX vs. The Competition Export to ExcelMetricAutonomix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.57M$6.78B$5.79B$10.19BDividend YieldN/A1.20%5.73%4.60%P/E Ratio-0.1926.0175.4026.02Price / SalesN/A192.48530.60120.19Price / CashN/A22.1825.8129.91Price / Book0.345.0012.166.25Net Income-$11.41M$176.38M$3.29B$270.76M7 Day Performance-0.48%1.00%0.74%3.87%1 Month Performance-1.77%2.09%5.00%5.49%1 Year Performance-93.23%10.96%62.55%25.86% Autonomix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMIXAutonomix Medical2.4118 of 5 stars$1.11-4.3%$5.00+350.5%-93.2%$6.57MN/A-0.191Short Interest ↓COCHEnvoy Medical2.1009 of 5 stars$1.28-2.3%$9.25+622.7%-60.5%$27.55M$220K-0.9034Short Interest ↑Gap DownICUSeaStar Medical0.3934 of 5 stars$0.88+4.6%N/A-82.2%$24.44M$140K-0.332Short Interest ↓RVPRetractable Technologies1.2246 of 5 stars$0.81+1.6%N/A-9.7%$24.22M$38.16M-1.50240Short Interest ↑NRXSNeurAxis2.2336 of 5 stars$2.45+1.2%$7.00+185.7%-18.4%$24.19M$3.22M-1.3319Positive NewsShort Interest ↑PETVPetVivoN/A$0.85+3.2%N/A+50.8%$23.72M$1.05M-1.8920News CoverageIRIXIRIDEX0.7102 of 5 stars$1.36-1.4%N/A-34.3%$23.11M$49.74M-4.12120DRIODarioHealth1.6097 of 5 stars$9.14-0.7%$40.00+337.6%-62.5%$20.79M$27.15M-0.69200NXGLNexGel0.882 of 5 stars$2.31+4.1%N/A-11.4%$18.64M$8.69M-5.7710ALURAllurion Technologies1.7771 of 5 stars$2.17-0.6%$22.83+954.2%-85.9%$16.81M$32.11M-0.17501Short Interest ↑INBSIntelligent Bio Solutions0.7764 of 5 stars$1.76+7.0%N/A-10.5%$15.81M$3.05M-0.8610Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies Envoy Medical Competitors SeaStar Medical Competitors Retractable Technologies Competitors NeurAxis Competitors PetVivo Competitors IRIDEX Competitors DarioHealth Competitors NexGel Competitors Allurion Technologies Competitors Intelligent Bio Solutions Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMIX) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
